Growth • Kamada
KMDA
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
4,8%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
-2,5%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
-8,3%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
-14,6%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-15%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
11,5%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!